D. Garceau
D. Garceau publishes mostly in Physiology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Alzheimer's disease research and treatments and Dementia and Cognitive Impairment Research.
- World rank
- #2,662,346 of 7,710,434 ranked researchers
- Rank in Canada
- #86,724 of 183,316
- Works
- 61
- Citations
- 1.6k
- Citations per work
- 26.4
What does D. Garceau research?
D. Garceau's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (12%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3151.6%
- Health Sciences2236.6%
- Medicine1931.4%
- Health Professions35.2%
- Life Sciences711.8%
- 1Physiology14% of their works
- 2Molecular Biology12% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Psychiatry and Mental health6% of their works
- 5General Health Professions5% of their works
- 6Nephrology5% of their works
Research topics
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Parathyroid Disorders and Treatments
- Respiratory and Cough-Related Research
- Analytical Methods in Pharmaceuticals
- Health, Medicine and Society
- Aging, Elder Care, and Social Issues
Which keywords describe D. Garceau's research?
The keywords of their largest research topics: Cardiac Amyloidosis, Transthyretin, Aging, Alzheimer's Disease, Amyloid Hypothesis, Mild Cognitive Impairment, Tau Pathology and Chronic Cough.
- Patient Rights
- Green Analytical Chemistry
- Caregiving
- FGF23
- Chronic Cough
- Mild Cognitive Impairment
- Alzheimer's Disease
- Transthyretin
- Cardiac Amyloidosis
- Aging
- Amyloid Hypothesis
- Tau Pathology
- Cough Reflex Sensitivity
- phosphate
- Elderly
- Healthcare Legislation
- Pharmaceutical Analysis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Cardiac Amyloidosis151 topic
- Transthyretin151 topic
- Aging122 topics
- Alzheimer's Disease81 topic
- Amyloid Hypothesis81 topic
- Mild Cognitive Impairment81 topic
- Tau Pathology81 topic
- Chronic Cough71 topic
- Cough Reflex Sensitivity71 topic
- FGF2371 topic
- phosphate71 topic
- Caregiving41 topic
- Elderly41 topic
- Green Analytical Chemistry41 topic
- Healthcare Legislation41 topic
- Patient Rights41 topic
- Pharmaceutical Analysis41 topic
Where does D. Garceau work?
D. Garceau's main affiliation in the publication record is Bellus Health (Canada), Canada.
How many publications and citations does D. Garceau have?
OpenAlex counts 61 works and 1,611 citations for D. Garceau, an h-index of 16, ranking #2,662,346 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about D. Garceau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.